1. Home
  2. SMTI vs TCPC Comparison

SMTI vs TCPC Comparison

Compare SMTI & TCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

N/A

Current Price

$32.54

Market Cap

322.2M

Sector

Health Care

ML Signal

N/A

Logo BlackRock TCP Capital Corp.

TCPC

BlackRock TCP Capital Corp.

N/A

Current Price

$4.12

Market Cap

337.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SMTI
TCPC
Founded
1982
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
322.2M
337.3M
IPO Year
2008
2006

Fundamental Metrics

Financial Performance
Metric
SMTI
TCPC
Price
$32.54
$4.12
Analyst Decision
Hold
Hold
Analyst Count
3
4
Target Price
★ $35.00
$4.17
AVG Volume (30 Days)
95.7K
★ 822.4K
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
★ 16.55%
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $15,586,976.00
N/A
Revenue This Year
$13.07
N/A
Revenue Next Year
$14.23
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 32.47
N/A
52 Week Low
$16.05
$3.08
52 Week High
$35.52
$6.25

Technical Indicators

Market Signals
Indicator
SMTI
TCPC
Relative Strength Index (RSI) 45.19 49.22
Support Level $30.40 $4.07
Resistance Level $34.01 $4.24
Average True Range (ATR) 1.00 0.13
MACD 0.06 -0.02
Stochastic Oscillator 75.84 31.03

Price Performance

Historical Comparison
SMTI
TCPC

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve its investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights, or direct equity investments.

Share on Social Networks: